Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial

Published:2019-06 Issue:2 Volume:104 Page:409-414
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Casey Dana L.,Kushner Brian H.,Cheung Nai-Kong V.,Modak Shakeel,Basu Ellen M.,Roberts Stephen S.,LaQuaglia Michael P.,Wolden Suzanne L.

Funder

National Institutes of Health

Band of Parents

Y-mabs Therapeutics

Abpro-Labs Inc.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference30 articles.

1. Long-term complications in survivors of advanced stage neuroblastoma;Laverdiere;Pediatr Blood Cancer,2005

2. Reduction in late mortality among 5-year survivors of childhood cancer;Armstrong;N Engl J Med,2016

3. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery;Kushner;J Clin Oncol,2001

4. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma;Bradfield;Cancer,2004

5. Excellent local control from radiation therapy for high-risk neuroblastoma;Gatcombe;Int J Radiat Oncol Biol Phys,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field;Radiotherapy and Oncology;2024-09

2. A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma;Clinical Oncology;2024-06

3. Local MRI before and after Tumor Resection in Neuroblastoma: Impact of Residual Disease on Event Free Survival;Journal of Clinical Medicine;2023-11-24

4. Treatment of High-Risk Neuroblastoma;Children;2023-07-28

5. Children's Oncology Group's 2023 blueprint for research: Radiation oncology;Pediatric Blood & Cancer;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3